{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:13:45Z","timestamp":1718496825674},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ghir.2024.101593","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T14:20:31Z","timestamp":1713709231000},"page":"101593","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate-specific antigen (PSA) levels in men with Prader-Willi syndrome"],"prefix":"10.1016","volume":"76","author":[{"given":"Anna","family":"Oskarsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"H\u00f6ybye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ghir.2024.101593_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","article-title":"Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction","volume":"9","author":"Tauber","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2024.101593_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00431-002-1132-4","article-title":"Genetic obesity study Group of Italian Society of pediatric endocrinology and diabetology (SIEDP). Hypogonadism and pubertal development in Prader-Willi syndrome","volume":"162","author":"Crin\u00f2","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ghir.2024.101593_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04161.x","article-title":"Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome","volume":"76","author":"Radicioni","year":"2012","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2024.101593_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.49","article-title":"Gonadal function and testicular histology in males with Prader-Willi syndrome","volume":"2","author":"Matsuyama","year":"2019","journal-title":"Endocrinol. Diabetes Metab."},{"issue":"5","key":"10.1016\/j.ghir.2024.101593_bb0025","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/ijms22052705","article-title":"Prader-Willi syndrome and hypogonadism: a review article","volume":"22","author":"Noordam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ghir.2024.101593_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041993","article-title":"Hypogonadism in patients with Prader Willi syndrome: a narrative review","volume":"22","author":"Napolitano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ghir.2024.101593_bb0035","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1530\/EC-21-0277","article-title":"Hypogonadism in the Prader-Willi syndrome from birth to adulthood: a 28-year experience in a single Centre","volume":"10","author":"Kherra","year":"2021","journal-title":"Endocr Connect."},{"issue":"9","key":"10.1016\/j.ghir.2024.101593_bb0040","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/ajmg.a.36048","article-title":"Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study","volume":"161","author":"Kido","year":"2013","journal-title":"American Journal of Medical Genetics A."},{"issue":"19","key":"10.1016\/j.ghir.2024.101593_bb0045","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.3390\/jcm10194361","article-title":"Hypogonadism in adult males with Prader-Willi syndrome-clinical recommendations based on a Dutch cohort study, review of the literature and an international expert panel discussion","volume":"10","author":"Pellikaan","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.ghir.2024.101593_bb0050","doi-asserted-by":"crossref","first-page":"e1720","DOI":"10.1210\/clinem\/dgad312","article-title":"Malignancies in Prader-Willi syndrome: results from a large international cohort and literature review","volume":"108","author":"Pellikaan","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2024.101593_bb0055","series-title":"StatPearls [Internet]","article-title":"Prostate Specific Antigen. 2022 Nov 10","author":"David","year":"2023"},{"issue":"Pt 4","key":"10.1016\/j.ghir.2024.101593_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2788.2005.00641.x","article-title":"Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome","volume":"49","author":"H\u00f6ybye","year":"2005","journal-title":"J. Intellect. Disabil. Res."},{"issue":"3","key":"10.1016\/j.ghir.2024.101593_bb0065","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/MD.0000000000000410","article-title":"The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis","volume":"94","author":"Kang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.ghir.2024.101593_bb0070","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa141","article-title":"Prostate-specific antigen concentrations in response to testosterone treatment of severely Hypogonadal men","volume":"4","author":"Sachdev","year":"2020","journal-title":"J Endocr Soc."},{"issue":"19","key":"10.1016\/j.ghir.2024.101593_bb0075","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Ba\u00f1ez","year":"2007","journal-title":"JAMA"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637424000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637424000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:31:51Z","timestamp":1718465511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637424000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":15,"alternative-id":["S1096637424000236"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101593","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate-specific antigen (PSA) levels in men with Prader-Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101593"}}